+ Add Chrome Extension

CNBC

Jul 31, 2020
1  Likes 0  Comments

About this Deal

The U.S. government will pay Sanofi and GlaxoSmithKline up to $2.1 billion to develop and deliver 100 million doses of their potential coronavirus vaccine.

More than half of the $1.5 billion will be used to support further development of the vaccine, including clinical trials, with the remainder used for manufacturing and delivery of the 100 million doses, the companies said.

The announcement comes less than two weeks after the government said it would pay Pfizer and BioNTech $1.95 billion to produce 100 million doses of their vaccine.

🏷 Deal Tags

News Coronavirus Covid-19 vaccine
What's the matter?

💬 Comments

Thanks! Worked! 👍 🙏 🤩 💕 🥳 🔥 😍
👀 Related Deals